These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27271765)

  • 21. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
    Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes.
    Winchester DJ; Chang HR; Graves TA; Menck HR; Bland KI; Winchester DP
    J Am Coll Surg; 1998 Apr; 186(4):416-22. PubMed ID: 9544955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing lobular carcinoma of the male breast using the SEER database.
    Moten A; Obirieze A; Wilson LL
    J Surg Res; 2013 Dec; 185(2):e71-6. PubMed ID: 24071024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.
    Rafiemanesh H; Salehiniya H; Lotfi Z
    Asian Pac J Cancer Prev; 2016; 17(3):1393-7. PubMed ID: 27039778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease Severity, Presentation, and Clinical Outcomes Among Adolescents With Malignant Breast Neoplasms: A 20-Year Population-Based Outcomes Study From the SEER Database (1973-2009).
    Murthy V; Pawar S; Chamberlain RS
    Clin Breast Cancer; 2017 Aug; 17(5):392-398. PubMed ID: 28602452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.
    Lobbes MB; Vriens IJ; van Bommel AC; Nieuwenhuijzen GA; Smidt ML; Boersma LJ; van Dalen T; Smorenburg C; Struikmans H; Siesling S; Voogd AC; Tjan-Heijnen VC
    Breast Cancer Res Treat; 2017 Apr; 162(2):353-364. PubMed ID: 28132393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands.
    Siesling S; Tjan-Heijnen VC; de Roos M; Snel Y; van Dalen T; Wouters MW; Struikmans H; van der Hoeven JJ; Maduro JH; Visser O
    Breast Cancer Res Treat; 2014 Aug; 147(1):177-84. PubMed ID: 25106659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients.
    Azim HA; Malek RA; Azim HA
    Womens Health (Lond); 2014 Sep; 10(5):511-8. PubMed ID: 25335542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast.
    Borst MJ; Ingold JA
    Surgery; 1993 Oct; 114(4):637-41; discussion 641-2. PubMed ID: 8211676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
    Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
    Li CI; Daling JR; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Strom BL; Simon MS; Press MF; McDonald JA; Ursin G; Burkman RT; Deapen D; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):946-54. PubMed ID: 16702375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis.
    Mahar AL; Kagedan DJ; Hallet J; Coburn NG
    Breast; 2017 Jun; 33():34-37. PubMed ID: 28279886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.
    Brouckaert O; Laenen A; Smeets A; Christiaens MR; Vergote I; Wildiers H; Moerman P; Floris G; Neven P;
    Breast; 2014 Aug; 23(4):371-7. PubMed ID: 24530094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
    Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
    Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migraine in postmenopausal women and the risk of invasive breast cancer.
    Mathes RW; Malone KE; Daling JR; Davis S; Lucas SM; Porter PL; Li CI
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3116-22. PubMed ID: 18990752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
    Fondrinier E; Guérin O; Lorimier G
    Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.
    Calle EE; Feigelson HS; Hildebrand JS; Teras LR; Thun MJ; Rodriguez C
    Cancer; 2009 Mar; 115(5):936-45. PubMed ID: 19156895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM; Morrow M; Sellers TA
    JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.